Hyperinsulinism

Displaying 1 - 2 of 2CSV
Varkaris, A., Pazolli, E., Gunaydin, H., Wang, Q., Pierce, L., Boezio, A. A., Bulku, A., DiPietro, L., Fridrich, C., Frost, A., Giordanetto, F., Hamilton, E. P., Harris, K., Holliday, M., Hunter, T. L., Iskandar, A., Ji, Y., Larivée, A., LaRochelle, J. R., … Kipp, D. R. (2023). Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia. Cancer Discovery, 14(2), 240–257. https://doi.org/10.1158/2159-8290.cd-23-0944
Publication Date
Reyes Diaz, J. V., Jin, Y., Garber, K., Cossen, K. M., Li, Y., Jin, P., Li, H., & Ham, J. N. (2022). A homozygous exonic variant leading to exon skipping in ABCC8 as the cause of severe congenital hyperinsulinism. American Journal of Medical Genetics Part A, 188(8), 2429–2433. Portico. https://doi.org/10.1002/ajmg.a.62843
Publication Date